To improve medical research on marijuana.
USA115th CongressHR-4825| House
| Updated: 1/24/2018
Rob Bishop
Republican Representative
Utah
Cosponsors (15)
Chris Stewart (Republican)Mia B. Love (Republican)Jimmy Panetta (Democratic)John R. Curtis (Republican)Steve Cohen (Democratic)Dana Rohrabacher (Republican)Ro Khanna (Democratic)A. Drew Ferguson (Republican)Jacky Rosen (Democratic)Eleanor Holmes Norton (Democratic)Jamie Raskin (Democratic)James P. McGovern (Democratic)Jared Polis (Democratic)Earl Blumenauer (Democratic)Matt Gaetz (Republican)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Marijuana Effective Drug Studies Act of 2018 or the MEDS Act This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana. Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Law Enforcement
Administrative law and regulatory proceduresAlternative treatmentsDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsMedical researchResearch administration and funding
To improve medical research on marijuana.
USA115th CongressHR-4825| House
| Updated: 1/24/2018
Marijuana Effective Drug Studies Act of 2018 or the MEDS Act This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana. Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Rob Bishop
Republican Representative
Utah
Cosponsors (15)
Chris Stewart (Republican)Mia B. Love (Republican)Jimmy Panetta (Democratic)John R. Curtis (Republican)Steve Cohen (Democratic)Dana Rohrabacher (Republican)Ro Khanna (Democratic)A. Drew Ferguson (Republican)Jacky Rosen (Democratic)Eleanor Holmes Norton (Democratic)Jamie Raskin (Democratic)James P. McGovern (Democratic)Jared Polis (Democratic)Earl Blumenauer (Democratic)Matt Gaetz (Republican)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresAlternative treatmentsDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsMedical researchResearch administration and funding